Core Insights - LifeVantage Corporation reported a significant decline in revenue for the second quarter of fiscal 2026, with total revenue of $48.9 million, representing a 27.8% decrease compared to the same quarter in fiscal 2025 [5][10]. - The company announced a new $60 million share repurchase authorization, replacing the previous program, which reflects its commitment to returning capital to shareholders [13]. - LifeVantage is focusing on stabilizing its GLP-1 business and expanding its product portfolio, particularly with the LoveBiome line, while also planning to enter new international markets [4]. Financial Performance - Revenue for the second quarter of fiscal 2026 was $48.9 million, down 27.8% year-over-year, with a 32.6% decrease in the Americas region and a 2.1% decrease in the Asia/Pacific & Europe region [5][8]. - Gross profit was $36.2 million, or 74.0% of revenue, down from 80.5% in the same period last year, primarily due to a $2.4 million inventory obsolescence allowance related to the MindBody GLP-1 System [6][10]. - Net income for the quarter was $0.3 million, or $0.02 per diluted share, compared to $2.6 million, or $0.19 per diluted share, in the prior year [10][11]. Operational Highlights - Commissions and incentives expense decreased to $19.9 million, or 40.7% of revenue, from $32.5 million, or 48.0% of revenue, in the prior year, reflecting changes in promotional programs and customer mix [7][8]. - Selling, general and administrative (SG&A) expenses increased to $15.8 million, or 32.3% of revenue, compared to $18.6 million, or 27.5% of revenue, in the same period last year [8][9]. - The company generated $0.5 million in cash from operations during the first half of fiscal 2026, down from $8.6 million in the same period last year [12]. Strategic Initiatives - LifeVantage plans to launch several new products under the LoveBiome brand in the upcoming quarters, targeting high-growth categories [4]. - The company anticipates fiscal 2026 revenue in the range of $185 million to $200 million, with adjusted EBITDA expected between $15 million and $19 million [15]. - The company declared a cash dividend of $0.045 per common share, to be paid on March 16, 2026 [14].